These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 23596757)
41. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma. Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815 [TBL] [Abstract][Full Text] [Related]
42. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. Langlois NE; Lamb J; Eremin O; Heys SD J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959 [TBL] [Abstract][Full Text] [Related]
43. p53 and hepatoma-derived growth factor expression and their clinicopathological association with Ewing family tumour. Yang Y; Zhen T; Zhang F; Dai S; Kang L; Liang Y; Xue L; Han A J Clin Pathol; 2014 Mar; 67(3):235-42. PubMed ID: 24072730 [TBL] [Abstract][Full Text] [Related]
44. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797 [TBL] [Abstract][Full Text] [Related]
45. Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Pancione M; Forte N; Fucci A; Sabatino L; Febbraro A; Di Blasi A; Daniele B; Parente D; Colantuoni V Hum Pathol; 2010 Jun; 41(6):867-76. PubMed ID: 20129645 [TBL] [Abstract][Full Text] [Related]
46. Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features. Yin H; Zhang Q; Wang X; Li T; Wan Y; Liu Y; Zhu J Chin Med J (Engl); 2014; 127(3):423-9. PubMed ID: 24451945 [TBL] [Abstract][Full Text] [Related]
47. Expression of p16INK4a, alone or combined with p53, is predictive of better prognosis in colorectal adenocarcinoma in Tunisian patients. Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Amouri A; Frikha F; Ellouz S; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):562-8. PubMed ID: 22095233 [TBL] [Abstract][Full Text] [Related]
48. High Ki67 expression is an independent good prognostic marker in colorectal cancer. Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861 [TBL] [Abstract][Full Text] [Related]
49. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer. Yang B; Cao L; Liu J; Xu Y; Milne G; Chan W; Heys SD; McCaig CD; Pu J Cancer; 2015 May; 121(10):1570-80. PubMed ID: 25603912 [TBL] [Abstract][Full Text] [Related]
50. p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. Zeng ZS; Sarkis AS; Zhang ZF; Klimstra DS; Charytonowicz E; Guillem JG; Cordon-Cardo C; Cohen AM J Clin Oncol; 1994 Oct; 12(10):2043-50. PubMed ID: 7931472 [TBL] [Abstract][Full Text] [Related]
51. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence. Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369 [TBL] [Abstract][Full Text] [Related]
52. Tumor-infiltrating mast cells in colorectal cancer as a poor prognostic factor. Wu X; Zou Y; He X; Yuan R; Chen Y; Lan N; Lian L; Wang F; Fan X; Zeng Y; Ke J; Wu X; Lan P Int J Surg Pathol; 2013 Apr; 21(2):111-20. PubMed ID: 22649166 [TBL] [Abstract][Full Text] [Related]
53. Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. Nitti D; Belluco C; Montesco MC; Bertorelle R; Da Pian PP; Fassina A; Ninfo V; Chieco-Bianchi L; Lise M Eur J Cancer; 1998 May; 34(6):851-5. PubMed ID: 9797697 [TBL] [Abstract][Full Text] [Related]
54. Prognostic effect of p53 expression in patients with completely resected colorectal cancer. Liu BW; Liu Y; Liu JR; Feng ZX; Liu T Tumour Biol; 2014 Oct; 35(10):9893-6. PubMed ID: 24993094 [TBL] [Abstract][Full Text] [Related]
55. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers. Lim SC; Lee TB; Choi CH; Ryu SY; Kim KJ; Min YD Yonsei Med J; 2007 Jun; 48(3):495-501. PubMed ID: 17594159 [TBL] [Abstract][Full Text] [Related]
56. p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer. Wen S; Gao J; Zhang L; Zhou H; Fang D; Feng S Oncotarget; 2016 Nov; 7(46):75981-75995. PubMed ID: 27732955 [TBL] [Abstract][Full Text] [Related]
57. p53 protein accumulation as a prognostic marker in sporadic colorectal cancer. Lan YT; Chang SC; Li AF; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK Int J Colorectal Dis; 2007 May; 22(5):499-506. PubMed ID: 17021749 [TBL] [Abstract][Full Text] [Related]
58. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma. Zheng L; Xie G; Duan G; Yan X; Li Q PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952 [TBL] [Abstract][Full Text] [Related]
59. Accumulation of p53 in relation to long-term prognosis in colorectal carcinoma. Starzynska T; Bromley M; Marlicz K; Roberts SA; Ucinski M; Stern PL Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):183-6. PubMed ID: 9058631 [TBL] [Abstract][Full Text] [Related]
60. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. Fitzgerald S; Sheehan KM; O'Grady A; Kenny D; O'Kennedy R; Kay EW; Kijanka GS J Gastroenterol Hepatol; 2013 Jun; 28(6):967-74. PubMed ID: 23425061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]